Sepsis biomarkers: a review

By C. Pierrakos, Jean-Louis Vincent. Critical Care, 2010

1,357 citations recorded by the source corpus.

IntroductionBiomarkers can be useful for identifying or ruling out sepsis, identifying patients who may benefit from specific therapies or assessing the response to therapy.MethodsWe used an electronic search of the PubMed database using the key words "sepsis" and "biomarker" to identify clinical and experimental studies which evaluated a biomarker in sepsis.ResultsThe search retrieved 3370 references covering 178 different biomarkers.ConclusionsMany biomarkers have been evaluated for use in sepsis. Most of the biomarkers had been tested clinically, primarily as prognostic markers in sepsis; relatively few have been used for diagnosis. None has sufficient specificity or sensitivity to be routinely employed in clinical practice. PCT and CRP have been most widely used, but even these have limited ability to distinguish sepsis from other inflammatory conditions or to predict outcome.

Subfields: Epidemiology, Immunology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/9feff367956b8bb06e96f4f091c4862f0cc34705

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Michael Draugelis
2. Barbara E. Engelhardt
3. Corey J. Chivers
4. Li-Fang Cheng
5. Chao Yu
6. Jiming Liu

Citations in the corpus

• Sparse Multi-Output Gaussian Processes for Medical Time Series Prediction (2017, background): “However, accurate diagnosis of sepsis is difficult due to heterogeneous symptoms across patients (Pierrakos and Vincent, 2010).”